Mahmoud Koko1, Joshua E Motelow2, Kate E Stanley2, Dheeraj R Bobbili3, Ryan S Dhindsa2, Patrick May3. 1. Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. 2. Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, New York, USA. 3. Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Abstract
OBJECTIVE: We aimed to identify genes associated with genetic generalized epilepsy (GGE) by combining large cohorts enriched with individuals with a positive family history. Secondarily, we set out to compare the association of genes independently with familial and sporadic GGE. METHODS: We performed a case-control whole exome sequencing study in unrelated individuals of European descent diagnosed with GGE (previously recruited and sequenced through multiple international collaborations) and ancestry-matched controls. The association of ultra-rare variants (URVs; in 18 834 protein-coding genes) with epilepsy was examined in 1928 individuals with GGE (vs. 8578 controls), then separately in 945 individuals with familial GGE (vs. 8626 controls), and finally in 1005 individuals with sporadic GGE (vs. 8621 controls). We additionally examined the association of URVs with familial and sporadic GGE in two gene sets important for inhibitory signaling (19 genes encoding γ-aminobutyric acid type A [GABAA ] receptors, 113 genes representing the GABAergic pathway). RESULTS: GABRG2 was associated with GGE (p = 1.8 × 10-5 ), approaching study-wide significance in familial GGE (p = 3.0 × 10-6 ), whereas no gene approached a significant association with sporadic GGE. Deleterious URVs in the most intolerant subgenic regions in genes encoding GABAA receptors were associated with familial GGE (odds ratio [OR] = 3.9, 95% confidence interval [CI] = 1.9-7.8, false discovery rate [FDR]-adjusted p = .0024), whereas their association with sporadic GGE had marginally lower odds (OR = 3.1, 95% CI = 1.3-6.7, FDR-adjusted p = .022). URVs in GABAergic pathway genes were associated with familial GGE (OR = 1.8, 95% CI = 1.3-2.5, FDR-adjusted p = .0024) but not with sporadic GGE (OR = 1.3, 95% CI = .9-1.9, FDR-adjusted p = .19). SIGNIFICANCE: URVs in GABRG2 are likely an important risk factor for familial GGE. The association of gene sets of GABAergic signaling with familial GGE is more prominent than with sporadic GGE.
OBJECTIVE: We aimed to identify genes associated with genetic generalized epilepsy (GGE) by combining large cohorts enriched with individuals with a positive family history. Secondarily, we set out to compare the association of genes independently with familial and sporadic GGE. METHODS: We performed a case-control whole exome sequencing study in unrelated individuals of European descent diagnosed with GGE (previously recruited and sequenced through multiple international collaborations) and ancestry-matched controls. The association of ultra-rare variants (URVs; in 18 834 protein-coding genes) with epilepsy was examined in 1928 individuals with GGE (vs. 8578 controls), then separately in 945 individuals with familial GGE (vs. 8626 controls), and finally in 1005 individuals with sporadic GGE (vs. 8621 controls). We additionally examined the association of URVs with familial and sporadic GGE in two gene sets important for inhibitory signaling (19 genes encoding γ-aminobutyric acid type A [GABAA ] receptors, 113 genes representing the GABAergic pathway). RESULTS: GABRG2 was associated with GGE (p = 1.8 × 10-5 ), approaching study-wide significance in familial GGE (p = 3.0 × 10-6 ), whereas no gene approached a significant association with sporadic GGE. Deleterious URVs in the most intolerant subgenic regions in genes encoding GABAA receptors were associated with familial GGE (odds ratio [OR] = 3.9, 95% confidence interval [CI] = 1.9-7.8, false discovery rate [FDR]-adjusted p = .0024), whereas their association with sporadic GGE had marginally lower odds (OR = 3.1, 95% CI = 1.3-6.7, FDR-adjusted p = .022). URVs in GABAergic pathway genes were associated with familial GGE (OR = 1.8, 95% CI = 1.3-2.5, FDR-adjusted p = .0024) but not with sporadic GGE (OR = 1.3, 95% CI = .9-1.9, FDR-adjusted p = .19). SIGNIFICANCE: URVs in GABRG2 are likely an important risk factor for familial GGE. The association of gene sets of GABAergic signaling with familial GGE is more prominent than with sporadic GGE.
Authors: Quanli Wang; Ryan S Dhindsa; Keren Carss; Andrew R Harper; Abhishek Nag; Ioanna Tachmazidou; Dimitrios Vitsios; Sri V V Deevi; Alex Mackay; Daniel Muthas; Michael Hühn; Susan Monkley; Henric Olsson; Sebastian Wasilewski; Katherine R Smith; Ruth March; Adam Platt; Carolina Haefliger; Slavé Petrovski Journal: Nature Date: 2021-08-10 Impact factor: 69.504
Authors: Patrick May; Simon Girard; Merle Harrer; Dheeraj R Bobbili; Julian Schubert; Stefan Wolking; Felicitas Becker; Pamela Lachance-Touchette; Caroline Meloche; Micheline Gravel; Cristina E Niturad; Julia Knaus; Carolien De Kovel; Mohamad Toliat; Anne Polvi; Michele Iacomino; Rosa Guerrero-López; Stéphanie Baulac; Carla Marini; Holger Thiele; Janine Altmüller; Kamel Jabbari; Ann-Kathrin Ruppert; Wiktor Jurkowski; Dennis Lal; Raffaella Rusconi; Sandrine Cestèle; Benedetta Terragni; Ian D Coombs; Christopher A Reid; Pasquale Striano; Hande Caglayan; Auli Siren; Kate Everett; Rikke S Møller; Helle Hjalgrim; Hiltrud Muhle; Ingo Helbig; Wolfram S Kunz; Yvonne G Weber; Sarah Weckhuysen; Peter De Jonghe; Sanjay M Sisodiya; Rima Nabbout; Silvana Franceschetti; Antonietta Coppola; Maria S Vari; Dorothée Kasteleijn-Nolst Trenité; Betul Baykan; Ugur Ozbek; Nerses Bebek; Karl M Klein; Felix Rosenow; Dang K Nguyen; François Dubeau; Lionel Carmant; Anne Lortie; Richard Desbiens; Jean-François Clément; Cécile Cieuta-Walti; Graeme J Sills; Pauls Auce; Ben Francis; Michael R Johnson; Anthony G Marson; Bianca Berghuis; Josemir W Sander; Andreja Avbersek; Mark McCormack; Gianpiero L Cavalleri; Norman Delanty; Chantal Depondt; Martin Krenn; Fritz Zimprich; Sarah Peter; Marina Nikanorova; Robert Kraaij; Jeroen van Rooij; Rudi Balling; M Arfan Ikram; André G Uitterlinden; Giuliano Avanzini; Stephanie Schorge; Steven Petrou; Massimo Mantegazza; Thomas Sander; Eric LeGuern; Jose M Serratosa; Bobby P C Koeleman; Aarno Palotie; Anna-Elina Lehesjoki; Michael Nothnagel; Peter Nürnberg; Snezana Maljevic; Federico Zara; Patrick Cossette; Roland Krause; Holger Lerche Journal: Lancet Neurol Date: 2018-07-17 Impact factor: 44.182
Authors: Anna L Peljto; Christie Barker-Cummings; Vincent M Vasoli; Cynthia L Leibson; W Allen Hauser; Jeffrey R Buchhalter; Ruth Ottman Journal: Brain Date: 2014-01-26 Impact factor: 13.501
Authors: Costin Leu; Remi Stevelink; Alexander W Smith; Slavina B Goleva; Masahiro Kanai; Lisa Ferguson; Ciaran Campbell; Yoichiro Kamatani; Yukinori Okada; Sanjay M Sisodiya; Gianpiero L Cavalleri; Bobby P C Koeleman; Holger Lerche; Lara Jehi; Lea K Davis; Imad M Najm; Aarno Palotie; Mark J Daly; Robyn M Busch; Dennis Lal Journal: Brain Date: 2019-11-01 Impact factor: 13.501
Authors: Joshua Traynelis; Michael Silk; Quanli Wang; Samuel F Berkovic; Liping Liu; David B Ascher; David J Balding; Slavé Petrovski Journal: Genome Res Date: 2017-09-01 Impact factor: 9.043
Authors: Mark A Corbett; Thessa Kroes; Liana Veneziano; Mark F Bennett; Rahel Florian; Amy L Schneider; Antonietta Coppola; Laura Licchetta; Silvana Franceschetti; Antonio Suppa; Aaron Wenger; Davide Mei; Manuela Pendziwiat; Sabine Kaya; Massimo Delledonne; Rachel Straussberg; Luciano Xumerle; Brigid Regan; Douglas Crompton; Anne-Fleur van Rootselaar; Anthony Correll; Rachael Catford; Francesca Bisulli; Shreyasee Chakraborty; Sara Baldassari; Paolo Tinuper; Kirston Barton; Shaun Carswell; Martin Smith; Alfredo Berardelli; Renee Carroll; Alison Gardner; Kathryn L Friend; Ilan Blatt; Michele Iacomino; Carlo Di Bonaventura; Salvatore Striano; Julien Buratti; Boris Keren; Caroline Nava; Sylvie Forlani; Gabrielle Rudolf; Edouard Hirsch; Eric Leguern; Pierre Labauge; Simona Balestrini; Josemir W Sander; Zaid Afawi; Ingo Helbig; Hiroyuki Ishiura; Shoji Tsuji; Sanjay M Sisodiya; Giorgio Casari; Lynette G Sadleir; Riaan van Coller; Marina A J Tijssen; Karl Martin Klein; Arn M J M van den Maagdenberg; Federico Zara; Renzo Guerrini; Samuel F Berkovic; Tommaso Pippucci; Laura Canafoglia; Melanie Bahlo; Pasquale Striano; Ingrid E Scheffer; Francesco Brancati; Christel Depienne; Jozef Gecz Journal: Nat Commun Date: 2019-10-29 Impact factor: 14.919